H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Census population 204,851. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Port St. Lucie clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Port St. Lucie storefront.
Platelet Rich Plasma (PRP) Therapy in Port St. Lucie, FL for clinics & physicians. PRP therapy systems wit… Compliance support & pricing — contact Hawk Medical.
Port St. Lucie is a city under 250k (204,851 Census). CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Adult arthritis here is 27.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Adult obesity in Port St. Lucie is 30.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 27.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JN / First Coast Service Options, sibling states no other states. Florida Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy platelet rich plasma therapy elsewhere, use this page as a check: homologous-use language, current First Coast Service Options article IDs, and PLACES 13.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.1% of adults — 1.1 points above the U.S. 12% figure. Obesity is 30.5%; arthritis is 27.9%. That is place-level BRFSS modeling, not a clinic census and not a Port St. Lucie trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Florida.
Florida is in CMS MAC JN, administered by First Coast Service Options. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Ask for the IFU, the lot-traceability packet, and the First Coast Service Options article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Port St. Lucie fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Port St. Lucie, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Port St. Lucie is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Port St. Lucie — 1.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Port St. Lucie. Useful for joint-program math; still needs a diagnosis and privileging.
No Port St. Lucie storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.